CEL-SCI Corporation to Raise $1 Million in Registered Direct Offering
Business Wire (press release) VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, has agreed to sell common stock and warrants in a registered direct offering to European investors at a combined price of $0.76 for aggregate gross … |